A randomised, double-masked, placebo-controlled trial evaluating the efficacy and safety of teprotumumab for active thyroid eye disease in Japanese patients
一项随机、双盲、安慰剂对照试验,旨在评估替普鲁单抗治疗日本活动性甲状腺眼病患者的疗效和安全性
期刊:The Lancet Regional Health Western Pacific
影响因子:8.1
doi:10.1016/j.lanwpc.2025.101464
Hiromatsu, Yuji; Ishikawa, Eri; Kozaki, Ai; Takahashi, Yasuhiro; Tanabe, Mika; Hayashi, Ken; Imagawa, Yukihiro; Kaneda, Kazutoyo; Mimura, Masashi; Dai, Xiaoxian; Hayashida, Tomoko; Akamizu, Takashi